Cargando…

A 2021 Update on Syphilis: Taking Stock from Pathogenesis to Vaccines

In 2021 the scientific community’s efforts have been focused on solving the back-breaking challenge of the COVID-19 pandemic, but sexually transmitted infections (STI) are still one of the most common global health problems. Syphilis is a systemic disease caused by the spirochaete Treponema pallidum...

Descripción completa

Detalles Bibliográficos
Autores principales: Tiecco, Giorgio, Degli Antoni, Melania, Storti, Samuele, Marchese, Valentina, Focà, Emanuele, Torti, Carlo, Castelli, Francesco, Quiros-Roldan, Eugenia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8620723/
https://www.ncbi.nlm.nih.gov/pubmed/34832520
http://dx.doi.org/10.3390/pathogens10111364
_version_ 1784605288832172032
author Tiecco, Giorgio
Degli Antoni, Melania
Storti, Samuele
Marchese, Valentina
Focà, Emanuele
Torti, Carlo
Castelli, Francesco
Quiros-Roldan, Eugenia
author_facet Tiecco, Giorgio
Degli Antoni, Melania
Storti, Samuele
Marchese, Valentina
Focà, Emanuele
Torti, Carlo
Castelli, Francesco
Quiros-Roldan, Eugenia
author_sort Tiecco, Giorgio
collection PubMed
description In 2021 the scientific community’s efforts have been focused on solving the back-breaking challenge of the COVID-19 pandemic, but sexually transmitted infections (STI) are still one of the most common global health problems. Syphilis is a systemic disease caused by the spirochaete Treponema pallidum (TP) and is one of the oldest known diseases. Its incidence has increased in the last few years and syphilis still remains a contemporary plague that continues to afflict millions of people worldwide. Despite research improvements, syphilis pathogenesis is not completely clear; clinical presentation is very heterogeneous and the diagnosis can sometimes be difficult. Furthermore, few therapeutic options are available, and a vaccine has not been found yet. In this review, we describe the most recent evidence concerning the clinical manifestation, diagnosis, treatment and vaccine prospectives for this disease.
format Online
Article
Text
id pubmed-8620723
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-86207232021-11-27 A 2021 Update on Syphilis: Taking Stock from Pathogenesis to Vaccines Tiecco, Giorgio Degli Antoni, Melania Storti, Samuele Marchese, Valentina Focà, Emanuele Torti, Carlo Castelli, Francesco Quiros-Roldan, Eugenia Pathogens Review In 2021 the scientific community’s efforts have been focused on solving the back-breaking challenge of the COVID-19 pandemic, but sexually transmitted infections (STI) are still one of the most common global health problems. Syphilis is a systemic disease caused by the spirochaete Treponema pallidum (TP) and is one of the oldest known diseases. Its incidence has increased in the last few years and syphilis still remains a contemporary plague that continues to afflict millions of people worldwide. Despite research improvements, syphilis pathogenesis is not completely clear; clinical presentation is very heterogeneous and the diagnosis can sometimes be difficult. Furthermore, few therapeutic options are available, and a vaccine has not been found yet. In this review, we describe the most recent evidence concerning the clinical manifestation, diagnosis, treatment and vaccine prospectives for this disease. MDPI 2021-10-21 /pmc/articles/PMC8620723/ /pubmed/34832520 http://dx.doi.org/10.3390/pathogens10111364 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Tiecco, Giorgio
Degli Antoni, Melania
Storti, Samuele
Marchese, Valentina
Focà, Emanuele
Torti, Carlo
Castelli, Francesco
Quiros-Roldan, Eugenia
A 2021 Update on Syphilis: Taking Stock from Pathogenesis to Vaccines
title A 2021 Update on Syphilis: Taking Stock from Pathogenesis to Vaccines
title_full A 2021 Update on Syphilis: Taking Stock from Pathogenesis to Vaccines
title_fullStr A 2021 Update on Syphilis: Taking Stock from Pathogenesis to Vaccines
title_full_unstemmed A 2021 Update on Syphilis: Taking Stock from Pathogenesis to Vaccines
title_short A 2021 Update on Syphilis: Taking Stock from Pathogenesis to Vaccines
title_sort 2021 update on syphilis: taking stock from pathogenesis to vaccines
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8620723/
https://www.ncbi.nlm.nih.gov/pubmed/34832520
http://dx.doi.org/10.3390/pathogens10111364
work_keys_str_mv AT tieccogiorgio a2021updateonsyphilistakingstockfrompathogenesistovaccines
AT degliantonimelania a2021updateonsyphilistakingstockfrompathogenesistovaccines
AT stortisamuele a2021updateonsyphilistakingstockfrompathogenesistovaccines
AT marchesevalentina a2021updateonsyphilistakingstockfrompathogenesistovaccines
AT focaemanuele a2021updateonsyphilistakingstockfrompathogenesistovaccines
AT torticarlo a2021updateonsyphilistakingstockfrompathogenesistovaccines
AT castellifrancesco a2021updateonsyphilistakingstockfrompathogenesistovaccines
AT quirosroldaneugenia a2021updateonsyphilistakingstockfrompathogenesistovaccines
AT tieccogiorgio 2021updateonsyphilistakingstockfrompathogenesistovaccines
AT degliantonimelania 2021updateonsyphilistakingstockfrompathogenesistovaccines
AT stortisamuele 2021updateonsyphilistakingstockfrompathogenesistovaccines
AT marchesevalentina 2021updateonsyphilistakingstockfrompathogenesistovaccines
AT focaemanuele 2021updateonsyphilistakingstockfrompathogenesistovaccines
AT torticarlo 2021updateonsyphilistakingstockfrompathogenesistovaccines
AT castellifrancesco 2021updateonsyphilistakingstockfrompathogenesistovaccines
AT quirosroldaneugenia 2021updateonsyphilistakingstockfrompathogenesistovaccines